MedPlus Health Services Limited (BOM:543427)
India flag India · Delayed Price · Currency is INR
808.85
+1.65 (0.20%)
At close: Jul 16, 2026

MedPlus Health Services Statistics

Total Valuation

BOM:543427 has a market cap or net worth of INR 96.24 billion. The enterprise value is 104.35 billion.

Market Cap96.24B
Enterprise Value 104.35B

Important Dates

The next confirmed earnings date is Tuesday, July 21, 2026.

Earnings Date Jul 21, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 120.14M
Shares Outstanding n/a
Shares Change (YoY) +0.06%
Shares Change (QoQ) -0.11%
Owned by Insiders (%) 13.28%
Owned by Institutions (%) 38.46%
Float 71.25M

Valuation Ratios

The trailing PE ratio is 43.82 and the forward PE ratio is 37.07.

PE Ratio 43.82
Forward PE 37.07
PS Ratio 1.40
PB Ratio 4.87
P/TBV Ratio 5.00
P/FCF Ratio 25.83
P/OCF Ratio 19.42
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.18, with an EV/FCF ratio of 28.01.

EV / Earnings 47.51
EV / Sales 1.51
EV / EBITDA 17.18
EV / EBIT 32.16
EV / FCF 28.01

Financial Position

The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.72.

Current Ratio 3.00
Quick Ratio 0.93
Debt / Equity 0.72
Debt / EBITDA 2.35
Debt / FCF 3.82
Interest Coverage 2.69

Financial Efficiency

Return on equity (ROE) is 11.82% and return on invested capital (ROIC) is 9.92%.

Return on Equity (ROE) 11.82%
Return on Assets (ROA) 5.56%
Return on Invested Capital (ROIC) 9.92%
Return on Capital Employed (ROCE) 10.01%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 2.76M
Profits Per Employee 87,835
Employee Count25,007
Asset Turnover 1.89
Inventory Turnover 3.73

Taxes

In the past 12 months, BOM:543427 has paid 557.24 million in taxes.

Income Tax 557.24M
Effective Tax Rate 20.24%

Stock Price Statistics

The stock price has decreased by -12.73% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -12.73%
50-Day Moving Average 860.17
200-Day Moving Average 827.56
Relative Strength Index (RSI) 35.03
Average Volume (20 Days) 32,609

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:543427 had revenue of INR 68.92 billion and earned 2.20 billion in profits. Earnings per share was 18.29.

Revenue68.92B
Gross Profit 18.08B
Operating Income 3.24B
Pretax Income 2.75B
Net Income 2.20B
EBITDA 4.03B
EBIT 3.24B
Earnings Per Share (EPS) 18.29
Full Income Statement

Balance Sheet

The company has 6.13 billion in cash and 14.24 billion in debt, with a net cash position of -8.11 billion.

Cash & Cash Equivalents 6.13B
Total Debt 14.24B
Net Cash -8.11B
Net Cash Per Share n/a
Equity (Book Value) 19.75B
Book Value Per Share 164.55
Working Capital 13.79B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.96 billion and capital expenditures -1.23 billion, giving a free cash flow of 3.73 billion.

Operating Cash Flow 4.96B
Capital Expenditures -1.23B
Depreciation & Amortization 789.71M
Net Borrowing -1.45B
Free Cash Flow 3.73B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 26.23%, with operating and profit margins of 4.71% and 3.19%.

Gross Margin 26.23%
Operating Margin 4.71%
Pretax Margin 3.99%
Profit Margin 3.19%
EBITDA Margin 5.85%
EBIT Margin 4.71%
FCF Margin 5.41%

Dividends & Yields

BOM:543427 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.06%
Shareholder Yield -0.06%
Earnings Yield 2.28%
FCF Yield 3.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:543427 is 1,168.71, which is 44.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target 1,168.71
Price Target Difference 44.49%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (3Y) 15.40%
EPS Growth Forecast (3Y) 14.56%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5